| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.153 | 23.415 | 24.889 | 27.873 | 32.981 | 32.938 | 32.631 | 0 | 44.428 | 51.436 |
| Total Income - EUR | 19.153 | 23.415 | 24.889 | 27.873 | 32.981 | 35.005 | 32.631 | 0 | 44.443 | 51.436 |
| Total Expenses - EUR | 14.025 | 15.149 | 23.798 | 20.468 | 22.182 | 21.068 | 19.808 | 0 | 30.942 | 43.928 |
| Gross Profit/Loss - EUR | 5.128 | 8.266 | 1.091 | 7.405 | 10.799 | 13.937 | 12.823 | 0 | 13.501 | 7.508 |
| Net Profit/Loss - EUR | 4.553 | 7.574 | 344 | 7.005 | 10.469 | 13.623 | 12.496 | 0 | 13.123 | 6.244 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 2 |
Check the financial reports for the company - Crismar Cabinet Medical Mangoianu Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 681 | 0 | 433 | 0 | 0 | 489 | 0 | 0 | 56 |
| Current Assets | 25.341 | 32.576 | 28.140 | 34.444 | 44.163 | 36.050 | 40.676 | 0 | 51.633 | 59.615 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 453 | 515 | 0 | 514 | 1.602 |
| Receivables | 0 | 702 | 1.037 | 1.816 | 42.091 | 31.990 | 31.716 | 0 | 34.970 | 38.908 |
| Cash | 25.341 | 31.874 | 27.102 | 32.628 | 2.072 | 3.607 | 8.445 | 0 | 16.150 | 19.105 |
| Shareholders Funds | 25.104 | 32.423 | 15.159 | 21.886 | 31.931 | 34.678 | 33.084 | 0 | 50.147 | 56.111 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 0 | 40 | 40 |
| Debts | 236 | 835 | 12.981 | 12.991 | 12.232 | 1.371 | 8.080 | 0 | 1.486 | 3.561 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Crismar Cabinet Medical Mangoianu Srl